Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

    This grant funds early stage trials of new drugs and neuromodulatory devices for psychiatric disorders, aiming to de-risk and attract further funding.

    Browse similar grants
    Neuroscience Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

    Funding for early-stage trials testing drugs or devices for mental disorder treatment, focusing on clinical effects and underlying mechanisms.

    HHS-NIH11Due Jan 18, 2027

    Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

    Funding for early testing of new drug or device treatments for mental disorders to understand mechanisms and assess clinical effects.

    HHS-NIH11Due Feb 17, 2027

    Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)

    This grant funds clinical trials testing mental health treatment and services interventions in community settings to improve access and quality.

    HHS-NIH11Due Jan 18, 2027

    NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)

    Supports investigator-initiated clinical trials for neurological disorders, from early exploratory studies to Phase 3 confirmatory and comparative effectiveness trials.

    HHS-NIH11Due Nov 9, 2026· 11d

    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

    Research grant to develop and test new psychosocial interventions for mental disorders, with focus on experimental therapeutics to translate basic science into treatments.

    HHS-NIH11Due Feb 17, 2027